With the government shutdown temporarily over, the SEC opened on Monday and IPO launches began to trickle onto the calendar, including billion-dollar biotech Alector (ALEC) and Virgin Trains USA (VTUS) . The first IPO of 2019, New Fortress Energy...read more
Andina Acquisition III, a blank check company formed to acquire a business in Latin America, raised $100 million by offering 10 million shares at $10. Andina Acquisition III plans to list on the Nasdaq under the symbol ANDAU. Cowen and Craig-Hallum Capital...read more
• With the SEC open, a wave of biotech IPOs may try price before mid-February • Two blank check companies are scheduled to raise a combined $300 million • Gossamer Bio and New Fortress Energy are set for mid-February IPOs, but could come sooner...read more
No companies went public this past week, during the post-Thanksgiving lull. Three healthcare deals joined the IPO calendar for next week. Messenger RNA developer Moderna (MRNA) is the week's largest offering, aiming to raise $500 million in the...read more
US IPO Weekly Recap: The SEC opens and New Fortress Energy is first through the door
With the government shutdown temporarily over, the SEC opened on Monday and IPO launches began to trickle onto the calendar, including billion-dollar biotech Alector (ALEC) and Virgin Trains USA (VTUS) . The first IPO of 2019, New Fortress Energy...read more
Latin America blank check Andina Acquisition III prices $100 million US IPO at $10
Andina Acquisition III, a blank check company formed to acquire a business in Latin America, raised $100 million by offering 10 million shares at $10. Andina Acquisition III plans to list on the Nasdaq under the symbol ANDAU. Cowen and Craig-Hallum Capital...read more
US IPO Week Ahead: A narrow window opens for a February IPO wave
• With the SEC open, a wave of biotech IPOs may try price before mid-February • Two blank check companies are scheduled to raise a combined $300 million • Gossamer Bio and New Fortress Energy are set for mid-February IPOs, but could come sooner...read more
US IPO Weekly Recap: A quiet week ahead of 2018's final stretch
No companies went public this past week, during the post-Thanksgiving lull. Three healthcare deals joined the IPO calendar for next week. Messenger RNA developer Moderna (MRNA) is the week's largest offering, aiming to raise $500 million in the...read more